The "no reflow" phenomenon following acute myocardial infarction: Mechanisms and treatment options

Journal of Cardiology

Volumn 64, Issue 2, 2014, Pages 77-85

  Kaul, Sanjiv ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Myocardial contrast echocardiography; Myocardial infarction; No reflow

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; CARDIOVASCULAR STENT; COLLATERAL CIRCULATION; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY OCCLUSION; CORONARY ARTERY THROMBOSIS; HEART CATHETERIZATION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HISTORY OF MEDICINE; HUMAN; NO REFLOW PHENOMENON; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; REVIEW; TREATMENT PLANNING; COMPLICATION; CORONARY OCCLUSION; CORONARY THROMBOSIS; ECHOGRAPHY; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PATHOLOGY; PROCEDURES; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY OCCLUSION; CORONARY THROMBOSIS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NO-REFLOW PHENOMENON; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905578499     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.03.008     Document Type: Review

References (79)

1. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., Masuyama T., Kitabatake A., Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992, 85:1699-1705.
2. Ragosta M., Camarano G.P., Kaul S., Powers E., Sarembock I.J., Gimple L.W. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation 1994, 89:2562-2569.
3. Lepper W., Kamp O., Vanoverschelde J.L., Franke A., Sieswerda G.T., Pasquet A., Kuhl H.P., Voci P., Visser C.A., Hanrath P., Hoffmann R. Intravenous myocardial contrast echocardiography predicts left ventricular remodeling in patients with acute myocardial infarction. J Am Soc Echocardiogr 2002, 15:849-856.
4. Janardhanan R., Swinburn J.M., Greaves K., Senior R. Usefulness of myocardial contrast echocardiography using low-power continuous imaging early after acute myocardial infarction to predict late functional left ventricular recovery. Am J Cardiol 2003, 92:493-497.
5. Dwivedi G., Janardhanan R., Hayat S.A., Swinburn J.A., Senior R. Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J Am Coll Cardiol 2007, 50:327-334.
6. Funaro S., La Torre G., Madonna M., Galiuto L., Scara A., Labbadia A., Canali E., Mattatelli A., Fedele F., Alessandrini F., Crea F., Agati L. Incidence, determinants, and prognostic value of reverse left ventricular remodeling after primary percutaneous coronary intervention: results of the acute myocardial infarction contrast imaging (AMICI) multicenter study. Eur Heart J 2009, 30:566-575. AMICI Investigators.
7. Appleby M.A., Angeja B.G., Dauterman K., Gibson C.M. Angiographic assessment of myocardial perfusion: TIMI myocardial perfusion (TMP) grading system. Heart 2001, 86:485-486.
8. Jacquier A., Boussel L., Amabile N., Bartoli J.M., Douek M.D., Moulin P., Paganelli G., Saeed F., Revel M., Croisille D.P. Multidetector computed tomography in reperfused acute myocardial infarction: assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging. Invest Radiol 2008, 43:773-781.
9. Sheehan H.L., Davis J.C. Renal ischaemia with failed reflow. J Pathol Bacteriol 1959, 78:105-120.
10. Krug A., de Rochemont W.M., Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 1966, 19:57-62.
11. Majno G.A., Ames A., Chaing J., Wright R.L. No reflow after cerebral ischemia. Lancet 1967, 290:569-570.
12. Kloner R.A., Ganote C.E., Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974, 54:1496-1508.
13. Sheridan F.M., Cole P.G., Ramage D. Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model. Circulation 1996, 93:1784-1787.
14. Jerome S.N., Smith C.W., Korthuis R.J. CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon. Am J Physiol 1993, 264:H479-H483.
15. Seydoux C., Goy J.-J., Davies G. Platelet and neutrophil imaging techniques in the investigation of the response to thrombolytic therapy and the no-reflow phenomenon. Am Heart J 1993, 125:1142-1147.
16. Michaels A.D., Gibson C.M., Barron H.V. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol 2000, 85:50b-60b.
17. Kloner R.A., Rude R.E., Carlson N., Maroko P.R., DeBoer L.W., Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?. Circulation 1980, 62:945-952.
18. Kaul S. Myocardial contrast echocardiography. 15 years of research and development. Circulation 1997, 96:3745-3760.
19. Kaul S. Myocardial contrast echocardiography: a 25 year retrospective. Circulation 2008, 118:291-308.
20. Kaul S., Ito H. The microvasculature in acute myocardial ischemia. Evolving concepts in pathophysiology, diagnosis and treatment. Part II. Circulation 2003, 109:310-315.
21. Jayaweera A.R., Wei K., Coggins M., Bin J.P., Goodman C., Kaul S. Role of capillaries in determining coronary blood flow reserve: new insights using myocardial contrast echocardiography. Am J Physiol 1999, 277:H2363-H2372.
22. Kaul S., Jayaweera A.R. Determinants of microvascular flow. Eur Heart J 2006, 27:2272-2274.
23. Kaul S., Jayaweera A.R. Myocardial capillaries and coronary flow reserve. J Am Coll Cardiol 2008, 52:1399-1401.
24. Villanueva F.S., Glasheen W.P., Sklenar J., Kaul S. Characterization of spatial patterns of flow within the re-perfused myocardium using myocardial contrast echocardiography: implications in determining the extent of myocardial salvage. Circulation 1993, 88:2596-2606.
25. Villanueva F.S., Camarano G., Ismail S., Goodman N.C., Sklenar J., Kaul S. Coronary reserve abnormalities during post-infarct reperfusion: implications for the timing of myocardial contrast echocardiography to assess myocardial viability. Circulation 1996, 94:748-754.
26. Kaul S., Villanueva F.S. Is the determination of myocardial perfusion necessary to evaluate the success of reperfusion when the infarct related artery is open?. Circulation 1992, 85:1942-1944.
27. Cobb F.R., Bache R.J., Rivas F., Greenfield J.C. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest 1976, 57:1359-1368.
28. Armiger L.C., Gavin J.B. Changes in the microvasculature of ischemic and infarcted myocardium. Lab Invest 1975, 33:51-56.
29. Ambrosio G., Weisman H.F., Mannisi J.A., Becker L.C. Progressive impairment of regional myocardial perfusion after initial restoration of post-ischemic blood flow. Circulation 1989, 80:1846-1861.
30. Sakuma T., Hayashi Y., Sumii K.M., Imazu M., Yamakido M. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 1998, 32:890-897.
31. White F.C., Sanders M., Bloor C.M. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. Am J Cardiol 1978, 42:234-243.
32. Johnson W.B., Malone S.A., Pantely G.A., Anselone C.G., Bristow J.D. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation 1988, 78:462-472.
33. Vanhaecke J., Flameng W., Borgers M., Jang I., Van de Werf F., De Geest H. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res 1990, 67:1201-1210.
34. Sabia P.J., Powers E.R., Ragosta M., Sarembock I.J., Burwell L.R., Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992, 327:1825-1831.
35. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97:473-483.
36. Keller M.W., Segal S.S., Kaul S., Duling B. The behavior of sonicated albumin microbubbles within the micro-circulation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989, 65:458-467.
37. Jayaweera A.R., Edwards N., Glasheen W.P., Villanueva F.S., Abbott R.D., Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography: comparison with radiolabeled red blood cells. Circ Res 1994, 74:1157-1165.
38. Reimer K.A., Jennings R.B. The "wave front phenomenon" of myocardial ischemic cell death, II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral blood flow. Lab Invest 1979, 40:633-644.
39. Schaper W., Frenzel H., Hort W. Experimental coronary artery occlusion, I: measurement of infarct size. Basic Res Cardiol 1979, 74:46-53.
40. Coggins M.P., Le D.E., Wei K., Goodman N.C., Lindner J.R., Kaul S. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation 2001, 104:2471-2477.
41. Sakuma T., Leong-Poi H., Fisher N.G., Goodman N.C., Kaul S. Further insights into the 'no-reflow' phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. J Am Soc Echocardiogr 2003, 16:15-21.
42. Sakuma T., Sklenar J., Leong-Poi H., Goodman N.C., Glover D.K., Kaul S. Molecular imaging identifies regions with microthromboemboli during primary angioplasty in acute coronary thrombosis. J Nucl Med 2004, 45:1194-1200.
43. Kaul S., Gillam L.D., Weyman A.E. Contrast echocardiography in acute myocardial ischemia: II - the effect of site of injection of contrast agent on the estimation of "area at risk" for necrosis after coronary occlusion. J Am Coll Cardiol 1985, 6:825-830.
44. Knight C.J. New insights into the pathophysiology of acute coronary occlusion. Eur Heart J 1999, 1(Suppl F):F1-F6.
45. Heusch G., Schulz R., Baumgart D., Haude M., Erbel R. Coronary microembolization. Prog Cardiovasc Dis 2001, 44:217-230.
46. Kotani J., Nanto S., Mintz G.S., Kitakaze M., Ohara T., Morozumi T., Nagata S., Hori M. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002, 106:1672-1677.
47. Tanaka A., Imanishi T., Kitabata H., Kubo T., Takarada S., Tanimoto T., Kuroi A., Tsujioka H., Ikejima H., Komukai K., Kataiwa H., Okouchi K., Kashiwaghi M., Ishibashi K., Matsumoto H., et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur Heart J 2009, 30:1348-1355.
48. Kloner R.A. Does reperfusion injury exist in humans?. J Am Coll Cardiol 1993, 21:537-545.
49. Reffelmann T., Hale S.L., Li G., Kloner R.A. Relationship between no-reflow and infarct size as influenced by different durations of ischemia and reperfusion. Am J Physiol 2002, 282:H766-H772.
50. Galiuto l, Garramone B., Scarà A., Rebuzzi A.G., Crea F., La Torre G., Funaro S., Madonna M., Fedele F., Agati L. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling. Results of the multicenter AMICI Study. J Am Coll Cardiol 2008, 51:552-559. on behalf of the AMICI Investigators.
51. Iwakura K., Ito H., Takiuchi S., Taniyama Y., Nakatsuchi Y., Negoro S., Higashino Y., Okamura A., Masuyama T., Hori M., Fujii K., Minamino T. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation 1996, 94:1269-1275.
52. Ito H., Maruyama A., Iwakura K., Takiuchi S., Masuyama T., Hori M., Higashino Y., Fujii K., Minamino T. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996, 93:223-228.
53. Harrison R.W., Aggarwal A., Ou F.S., Klein L.W., Rumsfeld J.S., Roe M.T., Wang T.Y. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol 2013, 112:178-184. American College of Cardiology National Cardiovascular Data Registry.
54. Chan W., Stub D., Clark D.J., Ajani A.E., Andrianopoulos N., Brennan A.L., New G., Black A., Shaw J.A., Reid C.M., Dart A.M., Duffy S.J. Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol 2012, 109:478-485. Melbourne Interventional Group Investigators.
55. Valgimigli M., Campo G., Malagutti P., Anselmi M., Bolognese L., Ribichini F., Boccuzzi G., de Cesare N., Rodriguez A.E., Russo F., Moreno R., Biondi-Zoccai G., Penzo C., Diaz Fernandez J.F., et al. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC: Cardiovasc Interven 2011, 4:51-62.
56. Li D., Qi H., Zhi L., Shan W., Wei-ying J. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. Clin Cardiol 2010, 33:E7-E12.
57. Ndrepepa G., Tiroch K., Fusaro M., Keta D., Seyfarth M., Byrne R.A., Pache J., Alger P., Mehilli J., Schömig A., Kastrati A. 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010, 55:2383-2389.
58. Bolognese L., Carrabba N., Parodi G., Santoro G.M., Buonamici P., Cerisano G., Antoniucci D. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004, 109:1121-1126.
59. Svilaas T., Vlaar P.J., van der Horst I.C., Diercks G.F.H., de Smet B.J.G.L., van den Heuvel A.F.M., Anthonio R.L., Jessurun G.A., Tan E., Suurmeijer A.J.H., Zijlstra F. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008, 358:557-567.
60. Vlaar P.J., Svilaas T., van der Horst I.W.C., Diercks G.F.H., Fokkema M.L., de Smet B.J.G.L., van den Heuvel A.F.M., Anthonio R.L., Jessurun G.A., Tan E., Suurmeijer A.J.H., Zijlstra F. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 2008, 371:1915-1920.
61. Burzotta F., Crea F. Thrombus-aspiration: a victory in the war against no reflow. Lancet 2008, 371:1889-1890.
62. Kumbhani D.J., Bavry A.A., Desai M.Y., Bangalore S., Bhatt D.L. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction under-going primary angioplasty. J Am Coll Cardiol 2013, 62:1409-1418.
63. Stone G.W., Webb J., Cox D.A., Brodie B.R., Qureshi M., Kalynych A., Turco M., Schultheiss H.P., Dulas D., Rutherford B.D., Antoniucci D., Krucoff M.W., Gibbons R.J., Jones D., Lansky A.J., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005, 293:1063-1072.
64. Ali A., Cox D., Dib N., Brodie B., Berman D., Gupta N., Browne K., Iwaoka R., Azrin M., Stapleton D., Setum C., Popma J. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 2006, 48:244-252. for the AIMI Investigators.
65. Thiele H., Schindler K., Friedenberger J., Eitel I., Fürnau G., Grebe E., Erbs S., Linke A., Möbius-Winkler S., Kivelitz D., Schuler G. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. The randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 2008, 118:49-57.
66. Danzi G., Sesana M., Capuano C., Mauri L., Centurini P.B., Baglini R. Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function. Am J Cardiol 2004, 94:35-39.
67. Sakuma T., Sari I., Goodman N.C., Lindner J.R., Klibanov A., Kaul S. Simultaneous αvβ3 and IIb/IIIa inhibition causes a marked reduction in infarct size following reperfusion in a canine model of acute coronary thrombosis: utility of in-vivo molecular imaging with myocardial contrast echocardiography. Cardiovasc Res 2005, 66:552-561.
68. Marzilli M., Orsini E., Marraccini P., Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000, 101:2154-2159.
69. Stoel M.G., Marques K.M.J., de Cock C.C., Bronzwaer J.G.F., von Birgelen C., Zijlstra F. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study. Catheter Cardiovasc Interven 2008, 71:283-289.
70. Ross A.M., Gibbons R.J., Stone G.W., Kloner R.A., Alexander R.W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005, 45:1775-1780. for the AMISTAD-II Investigators.
71. Ito H., Taniyama Y., Iwakura K., Nishikawa N., Masuyama T., Kuzuya T., Hori M., Higashino Y., Fujii K., Minamino M. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999, 33:654-660.
72. Ono H., Osanai T., Ishizaka H., Hanada H., Kamada T., Onodera H., Fujita N., Sasaki D., Matsunaga T., Okumura K. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J 2004, 148:e15.
73. Taniyama Y., Ito H., Iwakura K., Masuyama T., Hori M., Takiuchi S., Nishikawa N., Higashino Y., Fujii K., Minamino T. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997, 30:1193-1199.
74. Huang D., Qian J.Y., Ge L., Wang Q.B., Fan B., Yan Y., Zhang F., Ma J.Y., Yao K., Ge J. Effects of different route of intracoronary infusion of verapamil on no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction. Eur Heart J 2013, 34(Suppl 1). 10.1093/eurheartj/eht309.P3974.
75. Hillegass W.B., Dean N.A., Liao L., Rhinehart R.G., Myers P.R. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001, 37:1335-1343.
76. Amit G., Cafri C., Yaroslavtsev S., Fuchs S., Paltiel O., Abu-Ful A., Weinstein J.M., Wolak A., Ilia R., Zahger D. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J 2006, 152. 887e9-14.
77. Hale S.L., Kloner R.A. Cardioprotection with adenosine regulating agent, GP531: effects on no-reflow, infarct size and blood flow following ischemia/reperfusion in the rabbit. J Cardiovasc Pharm Therap 2010, 15:60-67.
78. Hale S.L., Herring M.J., Kloner R.A. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. JAHA 2013, 2. e004234. 10.1161/JAHA.112. 004234.
79. Duncker D.J., Klassen C.L., Ishibashi Y., Herrlinger S.H., Pavek T.J., Bache R.J. Effect of temperature on myocardial infarction in swine. Am J Physiol 1996, 270:H1189-H1199.